EDIT
Price
$1.04
Change
-$0.08 (-7.14%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
85.47M
26 days until earnings call
PCSA
Price
$0.34
Change
+$0.03 (+9.68%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.58M
Ad is loading...

EDIT vs PCSA

Header iconEDIT vs PCSA Comparison
Open Charts EDIT vs PCSABanner chart's image
Editas Medicine
Price$1.04
Change-$0.08 (-7.14%)
Volume$39.16K
Capitalization85.47M
Processa Pharmaceuticals
Price$0.34
Change+$0.03 (+9.68%)
Volume$989
Capitalization1.58M
EDIT vs PCSA Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. PCSA commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and PCSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (EDIT: $1.12 vs. PCSA: $0.31)
Brand notoriety: EDIT and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 48% vs. PCSA: 180%
Market capitalization -- EDIT: $85.47M vs. PCSA: $1.58M
EDIT [@Biotechnology] is valued at $85.47M. PCSA’s [@Biotechnology] market capitalization is $1.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, both EDIT and PCSA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 2 TA indicator(s) are bullish while PCSA’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 2 bullish, 6 bearish.
  • PCSA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PCSA is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -13.85% price change this week, while PCSA (@Biotechnology) price change was -19.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

EDIT is expected to report earnings on Apr 30, 2025.

PCSA is expected to report earnings on Mar 28, 2024.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($85.5M) has a higher market cap than PCSA($1.58M). EDIT YTD gains are higher at: -11.811 vs. PCSA (-64.641). PCSA has higher annual earnings (EBITDA): -11.79M vs. EDIT (-233.11M). EDIT has more cash in the bank: 270M vs. PCSA (2.89M). PCSA has less debt than EDIT: PCSA (96.8K) vs EDIT (35M). EDIT has higher revenues than PCSA: EDIT (32.3M) vs PCSA (0).
EDITPCSAEDIT / PCSA
Capitalization85.5M1.58M5,408%
EBITDA-233.11M-11.79M1,978%
Gain YTD-11.811-64.64118%
P/E RatioN/AN/A-
Revenue32.3M0-
Total Cash270M2.89M9,339%
Total Debt35M96.8K36,157%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITPCSA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNK24.990.20
+0.81%
Cinemark Holdings
STKH0.97N/A
+0.51%
Steakholder Foods Ltd
BSAC23.12-0.17
-0.73%
Banco Santander-Chile
LCTX0.42-0.02
-4.55%
Lineage Cell Therapeutics
XRX4.18-0.73
-14.87%
Xerox Holdings Corp

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
+4.17%
INO - PCSA
38%
Loosely correlated
N/A
ONCO - PCSA
35%
Loosely correlated
-4.29%
IMNN - PCSA
30%
Poorly correlated
-4.76%
EDIT - PCSA
28%
Poorly correlated
-5.08%
LVTX - PCSA
27%
Poorly correlated
-7.09%
More